Peptides International

Used In Pain Management Research and Drug Discovery, This Products Has Exciting Potential for Researchers

Peptides International Inc., announced today a change in its executive management.

Peptides International announced today that Dr. Satendra S. Chauhan has been appointed to the position of Chief Scientific Officer.

Peptisyntha and Peptides International announced that they have entered into a global partnership for the production of research grade peptide active pharmaceutical ingredients.

Peptides International announced today that its production and distribution have been certified to the ISO 9001:2008 (w/o design). Peptides International is among the select few suppliers of high quality peptides to have such a certification.

Peptides International announces new management structure, including new President and Chief Operating officers, and Vice President, following very successful year and expanded opportunities, especially in custom peptide synthesis.

Peptides International in partnership with Baylor University secures highly sought-after NIH RO1 grant

Peptides International announces publication of peer-reviewed scientific paper outlining possible applications of peptide toxins for drug discovery relating to autoimmune diseases.

Peptides International Inc. is pleased to announce its newest product offering, Maleimide Activated Keyhole Limpet Hemocyanin (mKLH). It is a popular choice to use as a carrier protein for haptens to assist in the activation of an immune response.

Peptides International Inc. announced today the addition of Dr. Michael Pennington to the company’s executive team, effective December 1st.